Skip to content
akaturk Academic measurement
Sign in Register

Academician

NERGİZ ERKUT

DOÇENT

KARADENİZ TEKNİK ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)

A quick look at recorded outputs — details below.

  • Articles 46
  • Projects 0
  • Books 3
  • Proceedings 76
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 2 Q2 16 Q3 24 Q4 5
WoS (JCR) Q1 2 Q2 2 Q3 10 Q4 33
TR Index 24 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 2
Avg percentile 52.1%
Top 1% share 0.0%
Top 10% share 3.8%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

46 publications total

Scopus (SJR)
Q1 2 Q2 16 Q3 24 Q4 5
WoS (JCR)
Q1 2 Q2 2 Q3 10 Q4 33
TR Index
24 articles

Article list

  1. 2026 The PERK signaling pathway as a marker of the unfolded protein response in patients with acute myeloid leukemia Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.6168 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 12.3%
  2. 2026 Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review Leukemia Research DOI 10.1016/j.leukres.2026.108239 YÖKSİS SJR Q2 JCR Q2 OpenAlex 42.8%
  3. 2025 Involvement of PERK and ATF6 signal pathways in indicating unfolded protein response in patients with chronic lymphocytic leukaemia Biomarkers DOI 10.1080/1354750X.2025.2553628 YÖKSİS SJR Q2 JCR Q3 OpenAlex 17.2%
  4. 2025 Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study Indian Journal of Hematology and Blood Transfusion DOI 10.1007/s12288-024-01790-2 YÖKSİS SJR Q3 JCR Q4 OpenAlex 76.0%
  5. 2025 Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology Journal of Thrombosis and Thrombolysis DOI 10.1007/s11239-024-03043-5 YÖKSİS SJR Q3 JCR Q4 OpenAlex 78.1%
  6. 2024 Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey Blood DOI 10.1182/blood-2024-193433 YÖKSİS SJR Q1 JCR Q1
  7. 2024 Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2024.2023.0430 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex top 10% OpenAlex 91.2%
  8. 2024 Yoğun Kemoterapi Alan Akut Lösemi Hastalarda Kanama ve Kanamanın Mortalite Üzerine Etkisi: Geriye Dönük Çalışma Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları DOI 10.5578/llm.202401112 YÖKSİS TR Index OpenAlex 7.6%
  9. 2024 Miyelodisplastik Sendromlar: Patogenez, Tanı, Sınıflama, Risk Değerlendirme Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları Dergisi DOI 10.5578/llm.202403152 YÖKSİS OpenAlex 27.8%
  10. 2024 Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program BLOOD DOI 10.1182/blood-2024-202019 YÖKSİS SJR Q1 JCR Q1
  11. 2023 Epstein-Barr Virüs (EBV) İlişkili Neoplastik ve Nonneoplastik Lenfoproliferatif Hastalıklarda Patologlar Tanı Sürecinde Nasıl İlerlemelidir? How Pathologists Should Proceed in the Diagnosis of Epstein-Barr Virus (EBV) Related Neoplastic and Nonneoplastic Lymphoproliferative Diseases? Türkiye'de Lösemi Lenfoma Myelom Araştırmaları DOI 10.5578/llm.20229901 YÖKSİS TR Index OpenAlex 5.4%
  12. 2022 Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia Int J Onc Hem DOI 10.2217/ijh-2021-0008 YÖKSİS SJR Q3 OpenAlex 57.1%
  13. 2022 Effect of Clinical, Endoscopic, Radiological Findings, and Complications on Survival in Patients with Primary Gastrointestinal Lymphoma TURKISH JOURNAL OF GASTROENTEROLOGY DOI 10.5152/tjg.2022.211003 YÖKSİS SJR Q3 JCR Q4 OpenAlex 67.8%
  14. 2021 The assessment of the Long Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine Galenos Yayinevi DOI 10.4274/tjh.galenos.2021.2021.0092 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 60.0%
  15. 2021 Diffüz Büyük B Hücreli Lenfomada Prognostik Skorlama Sistemlerinin Karşılaştırılması Bilimsel Tip Publishing House DOI 10.5578/llm.20219702 YÖKSİS TR Index OpenAlex 14.3%
  16. 2021 Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2021.2021.0435 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 18.4%
  17. 2020 Ekstranodal Diffüz Büyük B Hücreli Lenfomada Bcl-2 ve Myc Ekspresyon Birlikteliğinin Tedavi Yanıtı ve Prognoza Etkisinin Geriye Dönük Olarak Değerlendirilmesi LLM Dergi DOI 10.5578/llm.69230 YÖKSİS TR Index OpenAlex 1.2%
  18. 2018 Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia Central European Journal of Immunology DOI 10.5114/ceji.2018.80046 YÖKSİS SJR Q3 JCR Q4 OpenAlex 65.6%
  19. 2018 Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study Chemotherapy DOI 10.1159/000492531 YÖKSİS SJR Q2 JCR Q4 OpenAlex 81.7%
  20. 2017 Primary Adrenal Lymphoma: A Case Report Üroonkoloji Bülteni DOI 10.4274/uob.876 YÖKSİS TR Index JCR Q4 OpenAlex 19.4%

Back to academicians